Results about: diabetes
Age-related metabolic diseases have increased to epidemic proportions in all industrialized countries.
The group directed by Prof. Guinovart is involved in several projects on glycogen metabolism and its dysfunctions in diabetes and Lafora disease.
Researchers discover activators of a potential therapeutic target for the treatment of patients with diabetes and insulin resistance
A team headed by Antonio Zorzano at IRB Barcelona has identified activators of the mitochondrial protein Mitofusin 2 for the treatment of type 2 diabetes.
The protein is a key regulator of many mitochondrial functions, as well as of the cell as a whole.
More than 700 experts on biochemistry and molecular biology take part in the first edition of the FEBS3+ Congress
Professor Antonio Zorzano is the president of the FEBS3+ Congress as well as programme head at IRB Barcelona and the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Centre (CIBERDEM).